Searched for
HYDERABAD BIOPHARMACEUTICAL COMPANY
MSD inaugurates 2.5 lakh sq ft tech centre in HyderabadGlobal biopharmaceutical company MSD has opened a new technology centre in Hyderabad. This facility will enhance the company's digital, dat...- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...
- Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employeesFrench drugmaker Sanofi is set to significantly expand its global capability centre in Hyderabad. The company plans to more than double its...
- Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the wayTelangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the past year. This...
- Bristol Myers Squibb to invest Rs 800 crore to set up facility in Hyderabad for drug development, ITThe company plans to begin operations in Hyderabad later in 2023, with the potential over the next few years to employ approximately 1,500 ...
- Bharat Biotech raises Covaxin capacity by another 200 million doses a year“The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
- Dr Reddy’s inks licensing pact with Gilead for Remdesivir to treat Covid-19The Hyderabad headquartered drug maker will obtain technology transfer from Gilead for manufacturing of the drug wherein the Indian firm wo...
- GVK Bio extends partnership with Akaal PharmaGVK Bio has extended its tie-up with Australia's Akaal Pharma for scale-up of its novel topical AKP-11 ointment to support Phase II clinica...
- Ireland welcomes Indian pharma manufacturing units, offers sopsThe European country has already attracted Indian pharmaceutical companies such as Ranbaxy, Wockhardt and Reliance Life Sciences among othe...
- Biosimilars to replace 70% of chemical drugs in 2 decadesBiosimilars products are set to replace some 70% of global chemical drugs over the next couple of decades on account of safety parameters.
- Suven Life Sciences Q1 net profit up by 137%Suven Life Sciences Ltd net profit rise by 137% for Q1. Company to go ahead with amalgamation of Suven Nishtaa Pharma Pvt Ltd with Suven Li...
- Dr Reddy's, Merck to jointly develop biosimilarsmanufacturing of the compounds and will lead phase-III development.
- Stocks to Watch: EIH, ONGC, RNRL, Nava Bharat VenturesStocks that are likely to see some action in Monday’s trade are:
- Ranbaxy Labs launches Bonista-Teriparatide injection for OsteoporosisRanbaxy Laboratories has launched Bonista-Teriparatide injection for the treatment of Osteoporosis, in collaboration with Virchow Biotech, ...
- Zenotech to invest over Rs 90 cr in R&DGeneric biopharmaceutical company Zenotech Laboratories is set to invest over Rs 90 crore to strengthen its R&D pipeline.
- Zenotech plans to invest over Rs 90 crore in R&DHyderabad-based generic biopharmaceutical company Zenotech Laboratories is set to invest over Rs 90 crore to strengthen its R&D pipeline.
- Dr Reddy's begins phase 3 trial of new drugDr Reddy's Laboratories said on Wednesday it had reached an important milestone in testing an anti-diabetic molecule which could become the...
- Gujarat next biotech hub, number of cos up 50%Big pharma companies such as Zydus Healthcare plans to focus on biotech in a big way.
- French Merieux picks up 60% in Shantha BiotechIn a cross-border acquisition in the Indian biotech space, the E1.1-bn French major, Merieux Alliance, has snapped up a 60% stake in Hydera...
- Zenotech to issue shares to RanbaxyZenotech Laboratories Ltd said on Friday that it has received shareholders approval for issuing 20 lakh equity shares to the country's bigg...
Load More
